Nutritional Outlook

Nutritional Outlook, September 2013

Issue link: http://dc.cn.ubm-us.com/i/173262

Contents of this Issue

Navigation

Page 51 of 85

pre-and probiotics • 100% All-Natural Vitamin K2 (MK-7) from natto Specifcs, Specifcs! • 100% Trans-form • Highly Stable & Highly Bioavailable • No Solvents/Additives/Preservatives, nonGMO, Free of Allergens • Clinically-proven to support bone & cardiovascular health Promoting Bone and Cardiovascular Health ™ Bone Health Cardiovascular Kidney Health SEPT 26-28 Learn more at NattoMK7.com © 2013 Vesta Ingredients, Inc. 50 magenta cyan yellow black Health Baltimore Convention Center Baltimore, MD Booth #4714 info@VestaIngredients.com Windsor, NJ), believes that a critical advancement in prebiotics and probiotics has been in new delivery systems. For example, room temperature-stable Bacillus coagulans strains have allowed for the introduction of various new probiotic delivery systems. Sabinsa's LactoSpore, for example, has the multi-tasking ability to be incorporated into food-grade products such as breads and yogurts. 1-888-55VESTA www.VestaIngredients.com Suppliers are already commercializing pre- and probiotic ingredients with target applications. And many of these are being evaluated for condition-specifc efcacy. Deerland Enzymes has developed a patent-pending, non-enzymatic prebiotic that Deaton says supports the growth of healthy bacteria in the gut through a mechanism that is not fber- or starch-based. Te product, called PreforPro, is supposed to resolve issues of some conventional prebiotics: it is efective in small doses, within hours; it functions in both the small and large intestines, where it is unafected by varying gut environments; and it works with a broad spectrum of probiotic species. Another prebiotic innovation comes from Ingredion Inc. (Westchester, IL), which is currently awaiting publication of a study conducted on its short-chain fructooligosaccharides (scFOS) and an efect on bone turnover markers. "Changes in bone turnover markers suggest a more favorable bone health profle in women supplemented with calcium and scFOS," says Patrick Luchsinger, Ingredion nutrition marketing manager. On the probiotic side, there's no shortage of clinical, condition-specifc investigations. Scott Bush, vice president of probiotics marketing at DuPont Nutrition & Health (Madison, WI), says his company has taken an assertive condition-specifc approach to probiotic research, not only investigating impact upon digestive and immunity functions, but also efcacy for women's health, sports performance, infant/toddler/children's health, metabolic syndrome, and weight management applications. Studies in these areas are in various stages of completion, and expectations are that they should be published within the next six months. "Te most interesting development has been research with the strain Bifidobacterium 420," he says. "It's been looked at for its impact on metabolic syndrome. We've seen encouraging results there. Tere's also a phenomenal study that was done in Australia looking at probiotics and sports performance." In 2012 Ganeden launched Bonicel, a probiotic-based topical ingredient derived from the fermentation broth of Ganeden's hallmark probiotic, GanedenBC30. Te company recommends Bonicel for anti-aging and skin care products. Clinical trials on the ingredient show that a 5% inclusion rate in products reduces the appearance of fne lines, wrinkles, redness, and under-eye pufness. Nebraska Cultures is sponsoring its own human clinical trial, and the company expects the trial to demonstrate how its L. acidophilus DDS-1 probiotic produces lactase and thereby reduces the symptoms of lactose intolerance in humans. In the realm of immunity, specifcally those annoying colds, Pharmachem Laboratories Inc. (Kearny, NJ) ofers patented BIFIVIR, what the company deems the frst probiotic product with proven efcacy against colds. BIFIVIR combines fve probiotic strains (lactobacilli and bifidobacteria) and fructo-oligosaccharides that are september 2013 ■ NUTRITIONAL OUTLOOK ES315777_NO1309_050.pgs 09.04.2013 04:20 UBM

Articles in this issue

Links on this page

Archives of this issue

view archives of Nutritional Outlook - Nutritional Outlook, September 2013